In the present study we investigated the effects of chronic angiotensin II administration on urinary calcium/phosphate excretion, bone mineral density, bone remodeling and on osteoblast population—the cells responsible for the synthesis of bone matrix—in a well-established experimental model of hypertension, in the absence of possible confounding factors that could affect bone metabolism. Here, AGT is linked to hypertensive disorder.